首页> 美国卫生研究院文献>Human Genomics >Hydroxymethylation and tumors: can 5-hydroxymethylation be used as a marker for tumor diagnosis and treatment?
【2h】

Hydroxymethylation and tumors: can 5-hydroxymethylation be used as a marker for tumor diagnosis and treatment?

机译:羟甲基化和肿瘤:5-羟甲基化可以用作肿瘤诊断和治疗的标志物吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chemical structures of 5-methylcytosine (5mC) and its oxidized modifications. Cytosine is converted to 5-methylcytosine by both DNMT1 and DNMT3. 5-Methylcytosine is oxidized by TET1, TET2, or TET3 to yield 5-hydroxymethylcytosine (5hmC). By a similar reaction, using the same enzymes, 5-hydroxymethylcytosine is further oxidized to 5-formylcytosine (5fC) and 5-carboxycytosine (5caC). Both 5-formylcytosine and 5-carboxycytosine are depyrimidated by the thymine DNA glycosylase (TDG) and processed by the base excision repair (BER) pathway. All these pathways could result in unmodified cytosine. ɑ-KG = ɑ-ketoglutaric acid; SA = succinic acid
机译:5-甲基胞嘧啶(5mC)的化学结构及其氧化修饰。 DNMT1和DNMT3均将胞嘧啶转化为5-甲基胞嘧啶。 5-甲基胞嘧啶被TET1,TET2或TET3氧化,生成5-羟甲基胞嘧啶(5hmC)。通过类似的反应,使用相同的酶,将5-羟甲基胞嘧啶进一步氧化为5-甲酰基胞嘧啶(5fC)和5-羧胞嘧啶(5caC)。 5-甲酰基胞嘧啶和5-羧基胞嘧啶都被胸腺嘧啶DNA糖基化酶(TDG)脱嘧啶化,并通过碱基切除修复(BER)途径进行处理。所有这些途径都可能导致未修饰的胞嘧啶。 ɑ-KG=ɑ-酮戊二酸; SA =琥珀酸

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号